April 25, 2018 | Bently Reserve, San Francisco
Kimberly Clemenson, MS, MBA
Executive Director, Business Performance, Amgen
Kimberly has over 20 years of diverse Operations experience from various ventures into research, pharma/biotech, and entrepreneurship. She is currently Executive Director of Business Performance at Amgen and is leading an effort to accelerate potentially impactful therapies from discovery through launch to market at industry-leading speed. Kimberly joined Amgen in 2003 and has held positions of increasing responsibility in Operations Strategy, Global Operations Planning, CMC Lifecycle Management, and Global Product General Management. She spent the majority of her time as a Global Operations Leader, both leading product development teams and managing commercial products within the Operations space. Kimberly received her B.S. in Physics from Eastern Kentucky University, her M.S. in Health Physics from Texas A&M University, and an MBA from the University of California, Los Angeles. Kimberly is an avid cook and foodie and lives in the San Francisco Bay Area with her husband and two stepchildren.
Susan Desmond-Hellmann, MD, MPH
Chief Executive Officer, Bill & Melinda Gates Foundation
Susan Desmond-Hellmann, MD, MPH, is the 2018 recipient of the AWIS Pinnacle Award which recognizes her contributions in STEM as a scientist, physician, philanthropist, and mentor. As Chief Executive Officer of the Bill & Melinda Gates Foundation, Sue leads the organization’s vision for a world where every person has the opportunity to live a healthy, productive life. Under her watch, the foundation has also been pushing harder on women’s empowerment while working towards closing gender data gaps to help accelerate progress for women around the world. Forbes magazine has named her one of the world’s seven most “powerful innovators” and in her current role she champions global development by getting the right interventions, to the right populations, in the right places, to save lives. She is the recipient of numerous honors and awards. Sue was listed among Fortune magazine’s “top 50 most powerful women in business” for seven years and, in 2010, was inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine.
Holly J. Falk-Krzesinski, PhD
Vice President, Research Intelligence, Global Strategic Networks, Elsevier
Holly Falk-Krzesinski, PhD, is the Vice President, Research Intelligence on the Global Strategic Networks team at Elsevier, where her responsibilities center on how insights from data and analytics guide strategic planning for research institutions, funders, and science policy organizations. Dr. Falk-Krzesinski’s engagement activities include building partnerships around gender diversity and equity issues. Actively involved in promoting early career researchers and women leaders in STEM, Dr. Falk-Krzesinski co-launched the Chicago Collaboration for Women in STEM while a faculty member at Northwestern University, served as the editor-in-chief of the AWIS Magazine, is co-chair of the Gender Working Group at Elsevier, and co-authored Elsevier’s public report, “Gender in the Global Research Landscape.” Dr. Falk-Krzesinski has been an AWIS member since 1994.
Rachel Haurwitz, PhD
President and Chief Executive Officer, Caribou Biosciences, Inc.
Rachel is a co-founder of Caribou Biosciences and has been President and CEO since its inception. She has a research background in CRISPR-Cas biology, and is also a co-founder of Intellia Therapeutics. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. Rachel is an inventor on several patents and patent applications covering multiple CRISPR-derived technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. Rachel earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.
Talmadge E. King, Jr., MD
Dean, School of Medicine and Vice Chancellor – Medical Affairs, University of California, San Francisco
Talmadge E. King, Jr., MD is Dean of the School of Medicine and Vice Chancellor-Medical Affairs at the University of California, San Francisco. Dr. King is a member of the National Academy Medicine, the American Academy of Arts and Sciences, the Association of American Physicians, the American Clinical and Climatological Association and the Fleischner Society. He is a Master of the American College of Physicians and a Fellow of the American College of Chest Physicians. Dr. King is a past president of the ATS and Secretary/Treasurer of the American Board of Internal Medicine. He received the Trudeau Medal from the ATS and the Breathing for Life Award from the Foundation of the ATS. His research interest is the pathogenesis, diagnosis and management of inflammatory and immunologic lung injury. His bibliography comprises more than 300 publications. He has co-authored 11 books, including the reference book Interstitial Lung Disease, now in its 5th edition.
Evening News Anchor, KRON 4
Pamela Moore joined KRON 4 in March 1991 as an anchor and general assignment reporter and anchors the evening newscasts. Pam’s work on KRON 4’s five-part news series “About Race” garnered a number of awards, including a prestigious George Foster Peabody Award, the Pew Center Batten Prize for Civic Journalism, an In-Depth Reporting Award from the Northern California Chapter of the Society of Professional Journalists, top honors from the Black Filmmakers Hall of Fame and Best Documentary Award from the California Associated Press Television Radio Association. In addition, Pam was nominated for an Emmy for the special “Selma to Ferguson”. She has been inducted into the National Academy of Television Arts & Sciences Silver Circle, honoring her significant contribution to Northern California television and honored for her career achievements by the Society of Professional Journalism, NorCal. Pam is a member of the Bay Area Black Journalists Association, has worked in the past with the Black Journalists Association of Southern California, and was a former vice president for broadcast for the National Association of Black Journalists.
Rhona O’Leary, PhD
Global Head Portfolio and Product Development Strategy, Genentech
Rhona O’Leary is the Global Head of Portfolio and Product Development Strategy for Genentech. In this role, she is responsible for driving strategy for the Roche portfolio and the Product Development organization. Prior to this role, Rhona was Vice President gRED Business Operations and Project Team Leaders, responsible for leading drug development teams in multiple therapeutic areas, including Immunology, Neuroscience, Ophthalmology, Infectious Diseases and Metabolism.
Rhona received her Ph.D. in Biochemistry at Dublin City University, Ireland, in 1994 and then moved to Genentech for a Post-Doctoral position in the department of Recovery Sciences. She worked in the area of downstream processing for 13 years, and has had experiences in many aspect of biologics process development including early clinical development, commercial development, post-approval and validation. She was the Director of Early Stage Purification at Genentech for 4 years, leading the department responsible for purification of all clinical candidates from research through Phase II development.
Tony Prophet, MBA
Chief Equality Officer, Salesforce, Inc.
Tony Prophet leads Salesforce’s Equality initiatives, focusing on gender, LGBTQ, and racial issues—ensuring the company reflects the diversity and upholds the values of the communities it serves. He reports directly to the CEO and Chairman Marc Benioff. Prophet is also a board member of Gannett where he chairs the Transformation Committee. He also serves on the board of College Track.
Previously, Prophet was the corporate vice president of Windows and Search Marketing at Microsoft—responsible for the business planning and product marketing of the Windows, Bing, MSN and Cortana brands. Before that, he led the worldwide operations of what is now HP Inc. with direct responsibility exceeding $50B. Prior to that, he led the worldwide operations of Carrier Corporation. He began his career in consulting and rose from associate to partner with Booz Allen, co-founding the firm’s Los Angeles office.
Throughout his career, Prophet has worked for social justice including addressing the root causes of migratory worker flows, educating female workers in developing countries on reproductive health issues and reducing supply chain greenhouse gas footprint.
Prophet holds a BSIE degree from General Motors Institute and an MBA from the Stanford Graduate School of Business attending as a GM Fellow.
Sara Radcliffe, MPH
President and Chief Executive Officer, California Life Sciences Association (CLSA)
Sara Radcliffe was appointed the president and chief executive officer of the California Life Sciences Association (CLSA) in December 2014. She formerly served as the Executive Vice President for Health at the Biotechnology Industry Organization (BIO). Previously, Sara served as Senior Director, Biologics & Biotechnology at the Pharmaceutical Research and Manufacturers of America (PhRMA). She also served in the Alliance and Technology Group at SmithKline Beecham Pharmaceuticals as a Research and Development Policy Analyst, working on evaluation and communication of the promise, ethics, and impact of rapidly-developing technologies in DNA Research. In addition she worked for the Core Services Committee of the New Zealand Ministry of Health. Sara holds a Master of Public Health and a Master of Arts in Philosophy from the Johns Hopkins University, and a Bachelor of Arts from Wellesley College.
Melinda Richter, MBA
Global Head, Johnson & Johnson Innovation, JLABS
Melinda Richter, MBA, is the Global Head of Johnson & Johnson Innovation, JLABS. In her role, she fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage. Melinda has received numerous industry awards including: the PharmaVOICE 100; Fierce Biotech Top 15 Women; Most Influential Women in Business (San Francisco Business Times); MM&M 2017 Healthcare Transformer; BIO Super Hero; and Fast Company’s Most Innovative Company in Biotech. She serves on various boards and advisory panels and is currently board member and Treasurer of the California Life Sciences Association (CLSA).
Marc Tessier-Lavigne, FRS FRSC FMedSci
President and Bing Presidential Professor, Stanford University
Pioneering neuroscientist Marc Tessier-Lavigne became Stanford University’s 11th president on September 1, 2016. He returned to Stanford after serving as president of The Rockefeller University, a graduate biomedical research university in New York city. From 2001 to 2005, he was a professor of biological sciences at Stanford, where he held the Susan B. Ford Professorship in the Humanities and Sciences. He has also held faculty positions at the University of California, San Francisco, and executive positions at biotechnology company Genentech.
© 2017 Association for Women in Science. All Rights Reserved.